Skip to Content

Esmolol

In the US, Esmolol (esmolol systemic) is a member of the following drug classes: cardioselective beta blockers, group II antiarrhythmics and is used to treat Atrial Fibrillation, Atrial Flutter, High Blood Pressure, Intra- or Post-op SVT or Hypertension and Supraventricular Tachycardia.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C07AB09

CAS registry number (Chemical Abstracts Service)

0103598-03-4

Chemical Formula

C16-H25-N-O4

Molecular Weight

295

Therapeutic Categories

Antiarrhythmic agent, class II

Antihypertensive agent

β-adrenoceptor antagonist (beta blocker), cardioselective

Chemical Name

Benzenepropanoic acid, 4-[2-hydroxy-3-[(1-metyletyl)amino]propoxy]-, metyl ester

Foreign Names

  • Esmololum (Latin)
  • Esmolol (German)
  • Esmolol (French)
  • Esmolol (Spanish)

Generic Names

Brand Names

  • Brevibloc
    Baxter, Switzerland; Baxter, Cyprus; Baxter-RM, Italy
  • Brivebloc
    synth, Egypt
  • Esmocard
    Orpha-Devel, Cyprus; Providens, Croatia (Hrvatska)
  • Ai Luo
    Qilu, China
  • Ao Yi Xin
    AosaiKang Pharmaceutical, China
  • Brevibloc
    Agmar, Croatia (Hrvatska); Baxter, Belgium; Baxter, Canada; Baxter, Czech Republic; Baxter, Germany; Baxter, Denmark; Baxter, Spain; Baxter, Finland; Baxter, France; Baxter, Greece; Baxter, Hong Kong; Baxter, Malta; Baxter, Netherlands; Baxter, Norway; Baxter, Poland; Baxter, Sweden; Baxter Healthcare, Austria; Baxter Healthcare, United States; Bristol-Myers Squibb, Taiwan; Cristalia, Brazil; Delux, Pakistan; Eczacibasi Baxter, Turkey; ICI, Pakistan; Maruishi Pharmaceutical, Japan; Phebra, Australia; Salus, Slovenia
  • Crevimol
    Tecnofarma, Mexico
  • Esmocard
    AOP, Bosnia & Herzegowina; Orpha, Hungary; Orpha-Devel, Estonia; Orpha-Devel, Greece; Orpha-Devel, Lithuania; Orpha-Devel, Poland; Orpha Devel, Czech Republic
  • ESMOCARD
    Stragen, Germany
  • Esmolol Amomed
    Amomed Pharma, Austria
  • Esmolol HCl Orpha
    Orpha Devel, Netherlands
  • Esmolol Hydrochloride AOP Orphan
    AOP Orphan Pharmaceuticals, United Kingdom
  • Esmolol Orpha
    OrPha Swiss, Switzerland
  • Esmolol Richet
    Richet, Argentina
  • Xin Luo Ping
    Linuo Kefeng Pharmaceutical, China

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide